drugset

drugset / Trial / NCT00033072

Assessment of Potential Interactions Between Methamphetamine and Selegiline - 1

NCT00033072 ↗

Phase 1 Unknown 16 enrolled National Institute on Drug Abuse (NIDA)

RandomizedSingle-blindTreatment

Summary

The purpose of this study is to assess the potential interactions between intravenous methamphetamine and oral selegiline.

Timeline

Start: 2001-09
Primary completion: —
Completion: 2002-10

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Selegiline	Unknown	—	Oral

Indications